boswellia carteri gum extract

General Material Information

Preferred name	boswellia carteri gum extract
Trivial Name	Boswellia sacra, ext.
Short Description	extract obtained from the dried, ground gum of the olibanum, boswellia carterii, burseraceae
CAS Number	89957-98-2
ECHA Number	289-620-2
FDA UNII	Search
Synonyms	boswellia sacra gum extract extract obtained from the dried, ground gum of the olibanum, boswellia carterii, burseraceae frankincense gum extract olibanum gum extract Boswellia sacra, ext. Boswellia carteri, ext.

	boswellia carteri birdw. gum extract
Pubchem (sid):	135320262

Publications by PubMed
Major constituents of Boswellia carteri resin exhibit cyclooxygenase enzyme inhibition and antiproliferative activity.
Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.
In vitro screening for the tumoricidal properties of international medicinal herbs.
Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction.
Anti-inflammatory activity of resins from some species of the plant family Burseraceae.
Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model.
Composition and antibacterial activity of the essential oils of four commercial grades of Omani luban, the oleo-gum resin of Boswellia sacra FLUECK.
Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.

Wikipedia:	View
FAO:	OLIBANUM (FRANKINCENSE), MYRRH AND OPOPANAX RESINS AND OILS

Material listed in food chemical codex


Hazards identification

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements

Pictogram

Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Category:
cosmetic and fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice

Recommendation for boswellia carteri gum extract flavor usage levels up to:
	not for flavor use.

ClinicalTrials.gov:search

Daily Med:search

AIDS Citations:Search

Cancer Citations:Search

Toxicology Citations:Search

EPA Substance Registry Services (SRS):Registry

National Institute of Allergy and Infectious Diseases:Data

boswellia carteri birdw. gum extract

Chemidplus:0089957982